Age-dependent hypertrophy and fibrosis dynamics in hypertrophic cardiomyopathy: Insights from longitudinal CMR studies

Age-dependent hypertrophy and fibrosis dynamics in hypertrophic cardiomyopathy: Insights from longitudinal CMR studies

Background: This study aims to evaluate the progression of morphological and functional alterations over time in patients with hypertrophic cardiomyopathy (HCM) using Cardiac Magnetic Resonance (CMR). Methods: A retrospective analysis was conducted on patients with HCM who underwent serial CMR at 1....

Full description

Saved in:

Bibliographic Details
Main Authors:	Sebastian M. Haberkorn, Mukaram Rana, Vitali Koch, Simon Martin, Thomas Vogl, David M. Leistner, Marco M. Ochs
Format:	Article
Language:	English
Published:	Elsevier 2024-12-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	Hypertrophic Cardiomyopathy (HCM) Cardiac Magnetic Resonance (CMR) Left Ventricular Mass Late Gadolinium Enhancement (LGE) Prognosis Outcome
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906724002124
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Accelerated myocardial fibrosis in young to middle-aged patients with hypertrophic cardiomyopathy
by: Shiro Nakamori, et al.
Published: (2024-01-01)

The results of alcoholic septal ablation in the treatment of hypertrophic cardiomyopathy
by: B.M. Todurov, et al.
Published: (2020-12-01)

Definitional Challenges in Understanding Hypertrophic Cardiomyopathy
by: Jan M. Federspiel, et al.
Published: (2024-11-01)

Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations
by: Tatiana Saul, et al.
Published: (2024-12-01)

Three Novel Pathogenic Variants in Unrelated Vietnamese Patients with Cardiomyopathy
by: Dac Dai Tran, et al.
Published: (2024-11-01)

Clinical characteristics of female Fabry disease patients with hypertrophic cardiomyopathy with mid-ventricular obstruction
by: Natsuko Inagaki, et al.
Published: (2025-03-01)

A Case Study Identified a New Mutation in the TTN Gene for Inherited Hypertrophic Cardiomyopathy
by: Dong J, et al.
Published: (2025-01-01)

Hypertrophic Cardiomyopathy with Special Focus on Mavacamten and Its Future in Cardiology
by: Ewelina Młynarska, et al.
Published: (2024-11-01)

Sepsis-induced suicidal left ventricular in a patient with hypertrophic cardiomyopathy/hypertrophic obstructive cardiomyopathy
by: K Roshan Rao, et al.
Published: (2022-01-01)

Research Progress of Perioperative Anesthesia Management in Patients with Hypertrophic Cardiomyopathy
by: LIN Shuantong, et al.
Published: (2025-01-01)

Predictors of Myocardial Fibrosis Detected by CMR in Patients With Idiopathic PVCs
by: Ștefan Ailoaei, et al.
Published: (2024-11-01)

Hypertrophic cardiomyopathy with mid-ventricular obstruction and apical aneurysm
by: N.D. Oryshchyn, et al.
Published: (2016-11-01)

The D‐HCM score, a new diagnostic tool for distinguishing hypertrophic cardiomyopathy from hypertensive cardiopathy
by: G. Domain, et al.
Published: (2024-12-01)

Algorithm for Investigation of Fabry Disease in Cardiomyopathies
by: Sandra Marques e Silva, et al.
Published: (2024-10-01)

The influence of HIV infection on myocardial fibrosis diagnosed by cardiac magnetic resonance imaging in adults: a systematic review and meta-analysis of observation studies
by: Katongo Hope Mutengo, et al.
Published: (2025-01-01)

Cardiac Amyloidosis Masquerading as Hypertrophic Obstructive Cardiomyopathy: Co-existence or Coincidence?
by: Madhu Shukla, et al.
Published: (2024-07-01)

Effects of genetic mutations on left ventricular myocardial mechanics and fibrosis patterns in hypertrophic cardiomyopathy
by: Minjeong Kim, et al.
Published: (2025-01-01)

Association of Fibrate use with clinical expression of hypertrophic cardiomyopathy
by: Chan Soon Park, et al.
Published: (2024-12-01)

Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response
by: Anjali T. Owens, et al.
Published: (2024-09-01)

Mavacamten
by: Matthew W. Martinez, MD, et al.
Published: (2025-01-01)

Influencing and prognostic factors of end‐stage hypertrophic cardiomyopathy
by: Yisen Zhang, et al.
Published: (2024-12-01)

Obstructive hypertrophic cardiomyopathy: from genetic insights to a multimodal therapeutic approach with mavacamten, aficamten, and beyond
by: Khadija Sarwer, et al.
Published: (2024-12-01)

Association of liver fibrosis‐4 index with adverse outcomes in hypertrophic cardiomyopathy patients
by: Fuad A. Abdu, et al.
Published: (2024-12-01)

Serum biochemical profile in case of cardiorenal syndrome in cats with hypertrophic cardiomyopathy
by: Yu. A. Vatnikov, et al.
Published: (2024-12-01)

Tailored Therapies for Cardiogenic Shock in Hypertrophic Cardiomyopathy: Navigating Emerging Strategies
by: George E. Zakynthinos, et al.
Published: (2024-12-01)

Quantification of Replacement Fibrosis in Aortic Stenosis: A Narrative Review on the Utility of Cardiovascular Magnetic Resonance Imaging
by: Megan R. Rajah, et al.
Published: (2024-10-01)

Procedural Volume and Outcomes After Septal Reduction Therapies in Hypertrophic Obstructive Cardiomyopathy
by: Nirav Patel, et al.
Published: (2024-11-01)

Cryo-EM structures of cardiac muscle α-actin mutants M305L and A331P give insights into the structural mechanisms of hypertrophic cardiomyopathy
by: Hsiang-Ling Huang, et al.
Published: (2024-12-01)

PET-CT Imaging in Hypertrophic Cardiomyopathy: A Narrative Review on Risk Stratification and Prognosis
by: Patrícia Marques-Alves, et al.
Published: (2025-01-01)

Contribution of hypoxia-inducible factor 1alpha to pathogenesis of sarcomeric hypertrophic cardiomyopathy
by: Sarala Raj Murthi, et al.
Published: (2025-01-01)

High-sensitive cardiac troponin T and NT-proBNP are associated with the left ventricular apical thickness in apical hypertrophic cardiomyopathy
by: Meng Zhang, et al.
Published: (2025-01-01)

Differences in the Impact of Left Ventricular Outflow Tract Obstruction on Intraventricular Pressure Gradient in Feline Hypertrophic Cardiomyopathy
by: Miki Hirose, et al.
Published: (2024-11-01)

Hypertrophic cardiomyopathy: insights into pathophysiology and novel therapeutic strategies from clinical studies
by: Samuel Oluwadare Olalekan, et al.
Published: (2025-01-01)

Clinical burden of obstructive hypertrophic cardiomyopathy in France
by: Philippe Charron, et al.
Published: (2025-01-01)

Lateral hypertrophic cardiomyopathy: A case report
by: Emanuela Belmonte, et al.
Published: (2024-10-01)

Clinical Implications of Pan-Immune-inflammatory Values in Patients with Hypertrophic Cardiomyopathy
by: Levent PAY, et al.
Published: (2024-12-01)

The Effect of Coronary Artery Disease on the Prognosis of Hypertrophic Cardiomyopathy: A Multi-Center Cohort Study
by: Guoqing Hou, et al.
Published: (2025-01-01)

Validation of ACC/AHA and ESC Sudden Cardiac Death Risk Guidelines in Diverse Hypertrophic Cardiomyopathy Cohort: Stratification HCM Study
by: Murillo Oliveira Antunes, et al.
Published: (2024-12-01)

Patient-derived induced pluripotent stem cells to study non-canonical splicing variants associated with Hypertrophic Cardiomyopathy
by: Joanna Jager, et al.
Published: (2024-12-01)

Efficacy and safety of cardiac myosin inhibitors for symptomatic hypertrophic cardiomyopathy: a meta-analysis of randomized controlled trials
by: Anas Abunada, et al.
Published: (2025-01-01)